Cargando…

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone

PURPOSE: To find the maximum tolerated dose (MTD) of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors. METHODS: This was a Phase I study using cohort dose escalation of OSI-461 dosed orally twice daily in combination with mitoxantrone 12 mg/m(2) given on Day 1 of each...

Descripción completa

Detalles Bibliográficos
Autores principales:	Resta, Lee P., Pili, Roberto, Eisenberger, Mario A., Spitz, Avery, King, Serina, Porter, Jennifer, Franke, Amy, Boinpally, Ramesh, Carducci, Michael A., Sweeney, Christopher J.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028086/ https://www.ncbi.nlm.nih.gov/pubmed/20445979 http://dx.doi.org/10.1007/s00280-010-1328-7

Ejemplares similares

Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids
por: Dinter, Jonas, et al.
Publicado: (2023)

Mitoxantrone-Surfactant Interactions: A Physicochemical Overview
por: Enache, Mirela, et al.
Publicado: (2016)

Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
por: Najafian, Jamshid, et al.
Publicado: (2019)

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone
por: Altmann, Sharon E., et al.
Publicado: (2012)

The impact of age on a mitoxantrone-based tumor vaccine
por: Stonewall, Keven, et al.
Publicado: (2013)

Inhibitory Effect of Mitoxantrone on Collagen Synthesis in Dermal Fibroblasts
por: Kim, Kyung-Il, et al.
Publicado: (2022)

Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia
por: Amerigos Daddy J.C., Kambere, et al.
Publicado: (2020)

Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.
por: Vukovic, V., et al.
Publicado: (1997)

Anthracycline antibiotics derivate mitoxantrone—Destructive sorption and photocatalytic degradation
por: Štenglová-Netíková, Irena R., et al.
Publicado: (2018)

Enhancing the Therapeutic Efficacy of Daunorubicin and Mitoxantrone with Bavachinin, Candidone, and Tephrosin
por: Darzi, Sina, et al.
Publicado: (2019)

Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells
por: Skladanowski, A, et al.
Publicado: (2000)

Mitoxantrone and Analogues Bind and Stabilize i-Motif Forming DNA Sequences
por: Wright, Elisé P., et al.
Publicado: (2016)

Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice.
por: Rentsch, K. M., et al.
Publicado: (1997)

Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse
por: Im, Annie, et al.
Publicado: (2016)

Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes
por: Zhuang, Jie, et al.
Publicado: (2010)

Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study
por: Buttmann, Mathias, et al.
Publicado: (2016)

Impact of Anthocyanidins on Mitoxantrone-Induced Cytotoxicity and Genotoxicity: An In Vitro and In Vivo Analysis
por: Dhivya, Sridaran, et al.
Publicado: (2016)

CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemia
por: Halpern, Anna B., et al.
Publicado: (2018)

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
por: Anderson, Rebecca, et al.
Publicado: (2022)

Mitoxantrone targets both host and bacteria to overcome vancomycin resistance in Enterococcus faecalis
por: da Silva, Ronni A. G., et al.
Publicado: (2023)

Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins
por: Hajihassan, Zahra, et al.
Publicado: (2009)

Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis
por: Massé, Hélène, et al.
Publicado: (2009)

Cardiotoxicity of Mitoxantrone Treatment in a German Cohort of 639 Multiple Sclerosis Patients
por: Fleischer, Vinzenz, et al.
Publicado: (2014)

Nanodiamond–Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells
por: Toh, Tan-Boon, et al.
Publicado: (2014)

Characteristics of the Inhibitory Effect of Mitoxantrone and Pirarubicin on Lung Metastases of Colon Carcinoma 26
por: Iigo, Masaaki, et al.
Publicado: (1995)

A Case of Marburg's Variant of Multiple Sclerosis Successfully Treated with IVIg and Mitoxantrone
por: Manuel, Adarsh, et al.
Publicado: (2021)

The Increment of Genoprotective Effect of Melatonin due to "Autooptic" Effect versus the Genotoxicity of Mitoxantrone
por: M., Zamani, et al.
Publicado: (2020)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Mitoxantrone in NMO Spectrum Disorder in a Large Multicenter Cohort in French Caribbean
por: Chaumont, Hugo, et al.
Publicado: (2023)

Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound
por: Gopinath, Subash C. B., et al.
Publicado: (2005)

The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: Selective release of histone proteins
por: Hajihassan, Zahra, et al.
Publicado: (2011)

Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis
por: Chanvillard, Coralie, et al.
Publicado: (2012)

Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone
por: Alpay, Kemal, et al.
Publicado: (2014)

Vitamin C Effect on Mitoxantrone-Induced Cytotoxicity in Human Breast Cancer Cell Lines
por: Guerriero, Eliana, et al.
Publicado: (2014)

Potentiation by Tumor Necrosis Factor of Mitoxantrone Cytotoxicity to Human Ovarian Cancer Cell Lines
por: Russo, Patrizia, et al.
Publicado: (1992)

Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers
por: Kreft, Dennis, et al.
Publicado: (2018)

Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone
por: Chen, Yao, et al.
Publicado: (2018)

Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway
por: Park, See-Hyoung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_24rtij92126kmlci4jmjsg33os